Michael P.Earley

Practice Leader Private Equity

Chicago + 1.312.269.4349

Connect:

Share

Michael Earley represents parties around the globe in private equity and venture capital transactions, and he is co-head of Jones Day's global Private Equity Practice.

Michael advises fund sponsors, institutional investors, and investment advisors on a broad range of issues and transactions, including structuring private investment funds, portfolio investments, co-investment structures, internal governance and economics, and restructurings. He has worked with fund sponsors across a variety of assets classes, including private equity, venture capital, real estate, and infrastructure. Michael also works with a select group of institutional investors in connection with not only their investments in private equity funds but also their direct investment opportunities. A significant portion of his practice involves international funds and cross-border transactions.

Michael also advises issuers and investors in the formation and financing of private and emerging growth companies in sectors such as health care, life sciences, technology, transportation, and information services. He also counsels private companies on mergers and acquisitions, strategic relationships, corporate governance, and other general corporate matters.

In addition to his legal practice, Michael serves as a director of the Western Golf Association Evans Scholars Foundation and the Daniel Murphy Scholarship Fund.

Experience

  • ABB participates in Series B financing round of Atom PowerJones Day represented ABB in connection with the Series B round of financing of Atom Power, inventor of the world’s first and only digital circuit breaker.
  • Rising Point Capital acquires Conco HoldingsJones Day advised Rising Point Capital, LLC in its acquisition of Conco Holdings, a provider of low-pressure, mechanical heat exchanger tube cleaning and non-destructive testing services.
  • Concord Health Partners participates in $25 million investment in Pieces TechnologiesJones Day represented Concord Health Partners LLC in connection with their investment in Pieces Technologies, a healthcare artificial intelligence and technology company that connects health systems and the community to address clinical and social determinants of health.
  • Drive Capital forms Drive Capital Overdrive FundJones Day advised Drive Capital, LLC in the formation of venture capital funds Drive Capital Overdrive Fund I, L.P. and Drive Capital Overdrive Fund I (TE), L.P.
  • Concord Health Partners forms AHA Innovation Development FundJones Day represented Concord Health Partners LLC in connection with the formation of the AHA Innovation Development Fund, LP, a fund focused on investing in early-stage healthcare companies that provide products, services, and solutions to hospitals and health systems.
  • Drive Capital forms Drive Capital Fund IIIJones Day advised Drive Capital, LLC in the formation of venture capital funds, Drive Capital Fund III, L.P. and Drive Capital Fund III (TE), L.P.
  • Concord Health Partners invests in VitalTech™Jones Day represented Concord Health Partners LLC in connection with its purchase of Series A Convertible Preferred Stock in a private placement by VitalTech™, a provider of connected health and remote patient monitoring services.
  • Sky Island Capital forms special purpose vehicle and subsequent acquisition of controlling investment in Material Sciences CorporationJones Day represented Sky Island Capital LLC in connection with the formation of a special purpose vehicle and the subsequent acquisition of a controlling investment in Material Sciences Corporation, a provider of advanced materials and specialty coated metals.
  • Sky Island Capital forms special purpose vehicle and subsequent acquisition of controlling investment in Material Sciences CorporationJones Day represented Sky Island Capital LLC in connection with the formation of a special purpose vehicle and the subsequent acquisition of a controlling investment in Material Sciences Corporation, a provider of advanced materials and specialty coated metals.
  • Baird Capital acquires minority stake in AEGIS Energy RiskJones Day represented Baird Capital in connection with its minority stake investment in AEGIS Energy Risk, the leading fintech and advisory solutions provider for energy derivatives.
  • Baird Capital participates in Series A financing round by ChurnZeroJones Day represented Baird Capital in connection with its purchase of Series A Preferred Stock in a private placement by ChurnZero, a real-time customer success platform.
  • Baxter Ventures invests in Prescient SurgicalJones Day represented Baxter Ventures in connection with its purchase of Series B Convertible Preferred Stock in a private placement by Prescient Surgical, Inc., a manufacturer of advanced tools and technologies to fight and defend against the sources of surgical site infection.
  • Baird Capital sells interest in Radius to VistraJones Day represented Baird Capital in connection with its sale of interest in Radius, a leading global accounting and administration company which provides clients with increased resources, an enhanced knowledge base, and a dedicated proprietary software platform, to support overseas office activities, to Vistra.
  • Koch Disruptive Technologies leads $150 million investment in INSIGHTECJones Day advised Koch Disruptive Technologies, a subsidiary of Koch Industries, Inc. focused on finding and funding innovative and emerging companies, as the lead investor in a $150 million Series E funding round for INSIGHTEC, a commercial stage medical device company.
  • Greystar forms open ended core plus fund and acquires Monogram for approximately $4.4 billionJones Day advised Greystar Real Estate Partners on a number of related transactions culminating in the acquisition of Monogram Residential Trust, Inc. (a publicly traded REIT based in Plano, Texas), an owner, operator, and developer of luxury apartment communities with a significant presence in select coastal markets, in a transaction valued at approximately $4.4 billion, including the debt assumed or refinanced in connection with the transaction.
  • Shore Capital Partners portfolio company acquires TheraBond® family of products from Alliqua BioMedicalJones Day represented Shore Capital Partners, LLC in connection with the acquisition by portfolio company, Argentum Medical, LLC, a manufacturer of innovative wound care products, of TheraBond® family of products from Alliqua BioMedical, Inc., a regenerative technologies company committed to restoring tissue and rebuilding lives.
  • Baird Capital invests in Housecall ProJones Day represented Baird Capital in connection with its investment in Housecall Pro, a mobile software solution for home service professionals.
  • Baird Capital invests in AppCastJones Day represented Baird Capital in connection with its purchase of Series B Convertible Preferred Stock in a private placement by AppCast, Inc., a developer of programmatic job advertising technology.
  • AquaBounty completes purchase of Bell Fish Company's aquatic biomass farming facilityJones Day represented AquaBounty Technologies, Inc., a biotechnology company focused on enhancing productivity in the aquaculture market, in connection with its $14 million purchase of Bell Fish Company's aquatic biomass farming facility in Albany, Indiana.
  • Baxter Ventures invests in VitalConnectJones Day represented Baxter Ventures in connection with its purchase of Series C Preferred Stock in a private placement by VitalConnect, a leader in medical-grade wearable biosensor systems.
    • View All

    May 2020 White Paper

    Water Investment: Opportunities for New Economy Investors

    April 2018 Jones Day Publications

    Jones Day Talks Health Care & Life Sciences: False Claims and Private Equity, and Rideshare Apps Race into Patient Transportation

    February 2018 Commentaries

    DOJ Pursues PE Firm Based on Portfolio Company's Alleged Payment of Kickbacks

    May 2017 Commentaries

    SEC's Unwavering Focus on Disclosure of Valuation Methods and Calculation of IRRs by Fund Sponsors

    January 2017 Commentaries

    U.S. Regulatory Action Items for Investment Advisers (2017)

    Speaking Engagements

    • June 7, 2012
      Jones Day Chicago 2012 MCLE University
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.